vs

Side-by-side financial comparison of PUMA BIOTECHNOLOGY, INC. (PBYI) and TWIN DISC INC (TWIN). Click either name above to swap in a different company.

TWIN DISC INC is the larger business by last-quarter revenue ($90.2M vs $75.5M, roughly 1.2× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 0.3%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $1.2M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 10.3%).

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

Twin Disc, Inc. designs, manufactures, and distributes power transmission equipment for a wide range of applications, including marine, off-road vehicle, and industrial. The company was founded in 1918 to manufacture clutches for farm tractors. It is now a worldwide company with subsidiaries or sales offices in Asia, Europe, North America, Oceania, and South America.

PBYI vs TWIN — Head-to-Head

Bigger by revenue
TWIN
TWIN
1.2× larger
TWIN
$90.2M
$75.5M
PBYI
Growing faster (revenue YoY)
PBYI
PBYI
+27.4% gap
PBYI
27.7%
0.3%
TWIN
More free cash flow
PBYI
PBYI
$13.1M more FCF
PBYI
$14.4M
$1.2M
TWIN
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
10.3%
TWIN

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
PBYI
PBYI
TWIN
TWIN
Revenue
$75.5M
$90.2M
Net Profit
$22.4M
Gross Margin
69.3%
24.8%
Operating Margin
22.7%
2.3%
Net Margin
24.8%
Revenue YoY
27.7%
0.3%
Net Profit YoY
2334.3%
EPS (diluted)
$0.26
$1.55

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PBYI
PBYI
TWIN
TWIN
Q4 25
$75.5M
$90.2M
Q3 25
$54.5M
$80.0M
Q2 25
$52.4M
$96.7M
Q1 25
$46.0M
$81.2M
Q4 24
$59.1M
$89.9M
Q3 24
$80.5M
$72.9M
Q2 24
$47.1M
$84.4M
Q1 24
$43.8M
$74.2M
Net Profit
PBYI
PBYI
TWIN
TWIN
Q4 25
$22.4M
Q3 25
$8.8M
$-518.0K
Q2 25
$5.9M
$1.4M
Q1 25
$3.0M
$-1.5M
Q4 24
$919.0K
Q3 24
$20.3M
$-2.8M
Q2 24
$-4.5M
$7.4M
Q1 24
$-4.8M
$3.8M
Gross Margin
PBYI
PBYI
TWIN
TWIN
Q4 25
69.3%
24.8%
Q3 25
77.7%
28.7%
Q2 25
76.5%
31.0%
Q1 25
77.1%
26.7%
Q4 24
76.4%
24.1%
Q3 24
63.9%
26.5%
Q2 24
77.4%
29.7%
Q1 24
75.5%
28.2%
Operating Margin
PBYI
PBYI
TWIN
TWIN
Q4 25
22.7%
2.3%
Q3 25
17.6%
2.8%
Q2 25
12.7%
5.5%
Q1 25
8.7%
2.4%
Q4 24
22.6%
3.1%
Q3 24
27.4%
-0.2%
Q2 24
-4.6%
5.6%
Q1 24
-5.3%
4.9%
Net Margin
PBYI
PBYI
TWIN
TWIN
Q4 25
24.8%
Q3 25
16.2%
-0.6%
Q2 25
11.2%
1.5%
Q1 25
6.5%
-1.8%
Q4 24
1.0%
Q3 24
25.2%
-3.8%
Q2 24
-9.6%
8.8%
Q1 24
-11.0%
5.2%
EPS (diluted)
PBYI
PBYI
TWIN
TWIN
Q4 25
$0.26
$1.55
Q3 25
$0.17
$-0.04
Q2 25
$0.12
$0.10
Q1 25
$0.06
$-0.11
Q4 24
$0.40
$0.07
Q3 24
$0.41
$-0.20
Q2 24
$-0.09
$0.54
Q1 24
$-0.10
$0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PBYI
PBYI
TWIN
TWIN
Cash + ST InvestmentsLiquidity on hand
$97.5M
Total DebtLower is stronger
$22.7M
$44.5M
Stockholders' EquityBook value
$130.3M
$184.5M
Total Assets
$216.3M
$384.0M
Debt / EquityLower = less leverage
0.17×
0.24×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PBYI
PBYI
TWIN
TWIN
Q4 25
$97.5M
Q3 25
$94.4M
Q2 25
$96.0M
Q1 25
$93.2M
Q4 24
$101.0M
Q3 24
$96.7M
Q2 24
$96.8M
Q1 24
$107.2M
Total Debt
PBYI
PBYI
TWIN
TWIN
Q4 25
$22.7M
$44.5M
Q3 25
$34.0M
$43.7M
Q2 25
$45.3M
$31.4M
Q1 25
$56.7M
$40.8M
Q4 24
$68.0M
$24.9M
Q3 24
$79.3M
$29.8M
Q2 24
$90.7M
$25.8M
Q1 24
$102.0M
$17.0M
Stockholders' Equity
PBYI
PBYI
TWIN
TWIN
Q4 25
$130.3M
$184.5M
Q3 25
$115.3M
$160.3M
Q2 25
$104.7M
$164.0M
Q1 25
$97.1M
$149.5M
Q4 24
$92.1M
$147.0M
Q3 24
$71.1M
$157.5M
Q2 24
$48.5M
$154.7M
Q1 24
$51.0M
$146.3M
Total Assets
PBYI
PBYI
TWIN
TWIN
Q4 25
$216.3M
$384.0M
Q3 25
$202.9M
$363.5M
Q2 25
$194.9M
$355.6M
Q1 25
$196.2M
$332.9M
Q4 24
$213.3M
$307.4M
Q3 24
$220.7M
$323.5M
Q2 24
$205.0M
$312.1M
Q1 24
$214.1M
$288.8M
Debt / Equity
PBYI
PBYI
TWIN
TWIN
Q4 25
0.17×
0.24×
Q3 25
0.30×
0.27×
Q2 25
0.43×
0.19×
Q1 25
0.58×
0.27×
Q4 24
0.74×
0.17×
Q3 24
1.12×
0.19×
Q2 24
1.87×
0.17×
Q1 24
2.00×
0.12×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PBYI
PBYI
TWIN
TWIN
Operating Cash FlowLast quarter
$14.4M
$4.6M
Free Cash FlowOCF − Capex
$14.4M
$1.2M
FCF MarginFCF / Revenue
19.1%
1.4%
Capex IntensityCapex / Revenue
0.0%
3.7%
Cash ConversionOCF / Net Profit
0.20×
TTM Free Cash FlowTrailing 4 quarters
$41.7M
$-70.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PBYI
PBYI
TWIN
TWIN
Q4 25
$14.4M
$4.6M
Q3 25
$9.7M
$-7.5M
Q2 25
$14.1M
$16.4M
Q1 25
$3.6M
$3.2M
Q4 24
$15.6M
$8.7M
Q3 24
$11.0M
$-4.3M
Q2 24
$1.0M
$11.4M
Q1 24
$11.2M
$6.2M
Free Cash Flow
PBYI
PBYI
TWIN
TWIN
Q4 25
$14.4M
$1.2M
Q3 25
$9.7M
$-11.0M
Q2 25
$14.1M
$8.7M
Q1 25
$3.6M
$906.0K
Q4 24
$15.6M
$5.9M
Q3 24
$11.0M
$-6.7M
Q2 24
$1.0M
$10.3M
Q1 24
$4.0M
FCF Margin
PBYI
PBYI
TWIN
TWIN
Q4 25
19.1%
1.4%
Q3 25
17.7%
-13.7%
Q2 25
26.8%
9.0%
Q1 25
7.7%
1.1%
Q4 24
26.4%
6.5%
Q3 24
13.7%
-9.2%
Q2 24
2.1%
12.2%
Q1 24
5.5%
Capex Intensity
PBYI
PBYI
TWIN
TWIN
Q4 25
0.0%
3.7%
Q3 25
0.0%
4.3%
Q2 25
0.0%
8.0%
Q1 25
0.1%
2.8%
Q4 24
0.0%
3.1%
Q3 24
0.0%
3.2%
Q2 24
0.0%
1.3%
Q1 24
0.0%
2.9%
Cash Conversion
PBYI
PBYI
TWIN
TWIN
Q4 25
0.20×
Q3 25
1.10×
Q2 25
2.41×
11.55×
Q1 25
1.21×
Q4 24
9.42×
Q3 24
0.54×
Q2 24
1.54×
Q1 24
1.63×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons